Colorectal Cancer — Proceedings from a Multitumor Symposium in Partnership with Florida Cancer Specialists & Research Institute
Research To Practice | Oncology Videos
00:00
NICHE2 and Neoadjuvant IO in Colon Cancer
Chris Liu discusses NICHE2 neoadjuvant nivolumab/ipilimumab results showing high pathologic responses and excellent DFS.
Play episode from 04:10
Transcript
